drugset / Trial / NCT01514812

A Study to Investigate the Effect of YM150 on the Plasma Concentration of Digoxin in Healthy Subjects

NCT01514812

Phase 1 Completed 24 enrolled Astellas Pharma Inc
RandomizedCrossoverQuadruple-blind

Summary

This study is to evaluate the effect of YM150 on the plasma concentration of digoxin in healthy subjects.

Timeline

Start
2006-02
Primary completion
2006-04
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Digoxin Other / unclassified 0.25 mg
Subject darexaban Small molecule 120 mg Oral

Indications

No indication recorded.